"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
Descriptor ID |
D004345
|
MeSH Number(s) |
J01.576.655.750
|
Concept/Terms |
Drug Industry- Drug Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
- Pharmaceutical Industry
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in this website by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2003 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2007 | 2 | 1 | 3 |
2008 | 1 | 1 | 2 |
2009 | 2 | 1 | 3 |
2015 | 1 | 0 | 1 |
2016 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles.
-
D'Angelo AB, Grov C, Johnson J, Freudenberg N. Breaking Bad Patents: Learning from HIV/AIDS to make COVID-19 treatments accessible. Glob Public Health. 2021 10; 16(10):1523-1536.
-
Davidson MB. Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence. J Diabetes Complications. 2016 08; 30(6):981-5.
-
Akala EO, Adesina S, Ogunwuyi O. Computer Optimization of Biodegradable Nanoparticles Fabricated by Dispersion Polymerization. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010047.
-
Vlaar CP, Hern?ndez L. Symposium review: drug discovery, development and clinical research in academia. P R Health Sci J. 2009 Sep; 28(3):268-73.
-
Flaer PJ, Younis MZ. The Brazilian experiment: HIV drugs for all. J Health Care Finance. 2009; 36(2):90-6.
-
Younis MM, Younies H, Kisa A, Hartmann M, Hussain AA, Al-Amro A. A review of the effect of pharmaceutical firm drug announcements on stock option pricing. J Health Care Finance. 2009; 35(3):35-43.
-
Mayberry RM, Daniels P, Akintobi TH, Yancey EM, Berry J, Clark N. Community-based organizations' capacity to plan, implement, and evaluate success. J Community Health. 2008 Oct; 33(5):285-92.
-
Snyder L, Mueller PS. Research in the physician's office: navigating the ethical minefield. Hastings Cent Rep. 2008 Mar-Apr; 38(2):23-5.
-
Freudenberg N. Shattuck Lecture: improving American health. N Engl J Med. 2007 Dec 06; 357(23):2405; author reply 2406-7.
-
Segovis CM, Mueller PS, Rethlefsen ML, LaRusso NF, Litin SC, Tefferi A, Habermann TM. If you feed them, they will come: a prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical center. BMC Med Educ. 2007 Jul 12; 7:22.